Insulin-like growth factor 2 mRNA-binding protein 2: a potential link between type 2 diabetes mellitus and cancer

Type 2 diabetes mellitus (T2DM) and cancer share a variety of risk factors and pathophysiological features. It is becoming increasingly accepted that the 2 diseases are related, and that T2DM increases the risk of certain malignancies.This review summarizes recent advancements in the elucidation of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cao, Junguo (VerfasserIn) , Yan, Weijia (VerfasserIn) , Ma, Xiujian (VerfasserIn) , Huang, Haiyan (VerfasserIn) , Yan, Hong (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 June 2021
In: The journal of clinical endocrinology & metabolism
Year: 2021, Jahrgang: 106, Heft: 10, Pages: 2807-2818
ISSN:1945-7197
DOI:10.1210/clinem/dgab391
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1210/clinem/dgab391
Volltext
Verfasserangaben:Junguo Cao, Weijia Yan, Xiujian Ma, Haiyan Huang, and Hong Yan

MARC

LEADER 00000caa a2200000 c 4500
001 1789224497
003 DE-627
005 20230426075736.0
007 cr uuu---uuuuu
008 220210s2021 xx |||||o 00| ||eng c
024 7 |a 10.1210/clinem/dgab391  |2 doi 
035 |a (DE-627)1789224497 
035 |a (DE-599)KXP1789224497 
035 |a (OCoLC)1341441353 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Cao, Junguo  |e VerfasserIn  |0 (DE-588)1233777556  |0 (DE-627)175819801X  |4 aut 
245 1 0 |a Insulin-like growth factor 2 mRNA-binding protein 2  |b a potential link between type 2 diabetes mellitus and cancer  |c Junguo Cao, Weijia Yan, Xiujian Ma, Haiyan Huang, and Hong Yan 
246 3 3 |a Insulin-like growth factor two mRNA-Binding Protein two 
264 1 |c 1 June 2021 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.02.2022 
520 |a Type 2 diabetes mellitus (T2DM) and cancer share a variety of risk factors and pathophysiological features. It is becoming increasingly accepted that the 2 diseases are related, and that T2DM increases the risk of certain malignancies.This review summarizes recent advancements in the elucidation of functions of insulin-like growth factor 2 (IGF-2) messenger RNA (mRNA)-binding protein 2 (IGF2BP2) in T2DM and cancer.A PubMed review of the literature was conducted, and search terms included IGF2BP2, IMP2, or p62 in combination with cancer or T2DM. Additional sources were identified through manual searches of reference lists. The increased risk of multiple malignancies and cancer-associated mortality in patients with T2DM is believed to be driven by insulin resistance, hyperinsulinemia, hyperglycemia, chronic inflammation, and dysregulation of adipokines and sex hormones. Furthermore, IGF-2 is oncogenic, and its loss-of-function splice variant is protective against T2DM, which highlights the pivotal role of this growth factor in the pathogenesis of these 2 diseases. IGF-2 mRNA-binding proteins, particularly IGF2BP2, are also involved in T2DM and cancer, and single-nucleotide variations (formerly single-nucleotide polymorphisms) of IGF2BP2 are associated with both diseases. Deletion of the IGF2BP2 gene in mice improves their glucose tolerance and insulin sensitivity, and mice with transgenic p62, a splice variant of IGF2BP2, are prone to diet-induced fatty liver disease and hepatocellular carcinoma, suggesting the biological significance of IGF2BP2 in T2DM and cancer.Accumulating evidence has revealed that IGF2BP2 mediates the pathogenesis of T2DM and cancer by regulating glucose metabolism, insulin sensitivity, and tumorigenesis. This review provides insight into the potential involvement of this RNA binding protein in the link between T2DM and cancer. 
700 1 |a Yan, Weijia  |d 1994-  |e VerfasserIn  |0 (DE-588)1274781213  |0 (DE-627)1824544235  |4 aut 
700 1 |a Ma, Xiujian  |e VerfasserIn  |4 aut 
700 1 |a Huang, Haiyan  |e VerfasserIn  |4 aut 
700 1 |a Yan, Hong  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t The journal of clinical endocrinology & metabolism  |d Oxford : Oxford University Press, 1941  |g 106(2021), 10, Seite 2807-2818  |h Online-Ressource  |w (DE-627)323606261  |w (DE-600)2026217-6  |w (DE-576)094425523  |x 1945-7197  |7 nnas  |a Insulin-like growth factor 2 mRNA-binding protein 2 a potential link between type 2 diabetes mellitus and cancer 
773 1 8 |g volume:106  |g year:2021  |g number:10  |g pages:2807-2818  |g extent:12  |a Insulin-like growth factor 2 mRNA-binding protein 2 a potential link between type 2 diabetes mellitus and cancer 
856 4 0 |u https://doi.org/10.1210/clinem/dgab391  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220210 
993 |a Article 
994 |a 2021 
998 |g 1274781213  |a Yan, Weijia  |m 1274781213:Yan, Weijia  |d 50000  |e 50000PY1274781213  |k 0/50000/  |p 2 
998 |g 1233777556  |a Cao, Junguo  |m 1233777556:Cao, Junguo  |d 50000  |e 50000PC1233777556  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1789224497  |e 4055620985 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1789224497"],"doi":["10.1210/clinem/dgab391"]},"origin":[{"dateIssuedDisp":"1 June 2021","dateIssuedKey":"2021"}],"name":{"displayForm":["Junguo Cao, Weijia Yan, Xiujian Ma, Haiyan Huang, and Hong Yan"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Oxford ; Bethesda, Md.","dateIssuedKey":"1941","publisher":"Oxford University Press ; Endocrine Society","dateIssuedDisp":"1941-"}],"id":{"zdb":["2026217-6"],"eki":["323606261"],"issn":["1945-7197"]},"name":{"displayForm":["Endocrine Society"]},"pubHistory":["1.1941 -"],"titleAlt":[{"title":"JCEM"},{"title":"The Journal of clinical endocrinology"}],"part":{"extent":"12","text":"106(2021), 10, Seite 2807-2818","volume":"106","issue":"10","pages":"2807-2818","year":"2021"},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Insulin-like growth factor 2 mRNA-binding protein 2 a potential link between type 2 diabetes mellitus and cancerThe journal of clinical endocrinology & metabolism","note":["Gesehen am 30.03.2017"],"corporate":[{"role":"isb","display":"Endocrine Society","roleDisplay":"Herausgebendes Organ"}],"language":["eng"],"recId":"323606261","title":[{"subtitle":"JCEM","title":"The journal of clinical endocrinology & metabolism","title_sort":"journal of clinical endocrinology & metabolism"}]}],"physDesc":[{"extent":"12 S."}],"title":[{"title_sort":"Insulin-like growth factor 2 mRNA-binding protein 2","subtitle":"a potential link between type 2 diabetes mellitus and cancer","title":"Insulin-like growth factor 2 mRNA-binding protein 2"}],"person":[{"family":"Cao","given":"Junguo","display":"Cao, Junguo","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Yan, Weijia","given":"Weijia","family":"Yan"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Ma, Xiujian","given":"Xiujian","family":"Ma"},{"display":"Huang, Haiyan","roleDisplay":"VerfasserIn","role":"aut","family":"Huang","given":"Haiyan"},{"roleDisplay":"VerfasserIn","display":"Yan, Hong","role":"aut","family":"Yan","given":"Hong"}],"titleAlt":[{"title":"Insulin-like growth factor two mRNA-Binding Protein two"}],"recId":"1789224497","language":["eng"],"note":["Gesehen am 10.02.2022"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a CAOJUNGUOYINSULINLIK1202